December, 07 2025 Sunday 01:15 Hrs
Last update 11-9-2025
  • SENSEX :   85,712.37

  • Commodity broking firm in India447.05( 0.52%) 05-Dec-2025
top-arrow-market
Sensex 85712.37 447.05  (0.52) 05-Dec-2025
Previous Day Close
85265.32
Today's High/Low
High Low
  •  
  •  
85796.72 85078.12

Company News Details

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
119.5408865
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
0
52515.93
EPS(TTM)
Face Value()
Div & Yield %
0.6
5
0.11
 

Biocon Ltd
Biocon drops after brokerage downgrades stock to 'Sell'
Nov 20,2025
The brokerage reduced Biocon’s target to Rs 360 from Rs 430, implying a downside of 12.20% from the previous close of Rs 410. It said the company’s valuation has become expensive.

The broker trimmed valuation multiples across key business segments. The biosimilars business multiple was cut to 14x EBITDA from 20x, citing deteriorating market conditions and evolving USFDA guidelines. The generics division multiple was reduced to 14x from 16x due to weaker margins.

The brokerage acknowledged Biocon's strong global position in biosimilar R&D and execution, but warned that pricing pressure and an increasingly crowded competitive pipeline may hold back sales and keep earnings below earlier expectations.

Biocon is a global biopharma company dedicated to improving affordable access to therapies for chronic conditions such as diabetes, cancer, and autoimmune diseases.

On a consolidated basis, Biocon reported net profit of Rs 84.50 crore in Q2 September 2025 as against net loss of Rs 16 crore in Q2 September 2024. Net sales rose 20.24% YoY to Rs 4262.50 crore in Q2 September 2025.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.